Aims To conduct a systematic literature review to identify recent epidemiological, biomarker,
genetic and clinical evidence that expands our understanding of nonalcoholic fatty liver …

Introduction Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver
disease, with type 2 diabetes mellitus (T2DM) as a major predictor. Insulin resistance and …

Background and aim The aim of this study was to describe the frequency of non-alcoholic
fatty liver disease (NAFLD) in patients with diabetes mellitus (DM), hyperlipidemia, obesity …

Objectives: The purpose of conducting this study was to assess fatty liver disease and its
correlation with glycemic control in type 2 diabetes mellitus patients. In addition, evaluation …

Background Non-alcoholic fatty liver disease (NAFLD) is the commonest chronic liver
disease worldwide. We estimated the prevalence and predefined associated factors for …

Background: The main etiologies of hepatocellular carcinoma (HCC) were often hepatitis B
virus (HBV) or C and alcohol, rarely autoimmune and biliary diseases. Nonalcoholic fatty …

Background/aim In the current study, we aimed to assess the association of carbohydrate
quality index (CQI) with the risk of non-alcoholic fatty liver disease (NAFLD) in Iranian adults …

Objective: Non-Alcoholic Fatty Liver Disease (NAFLD) is emerging as a major public health
problem globally especially in patients with Type-2 Diabetes mellitus (T2DM). This study …

Background Dietary advanced glycation end products (AGEs) may contribute to increased
inflammation and oxidative stress as risk factors for chronic diseases such as liver disease …

A two-arm randomized open labeled controlled clinical trial was conducted on 50 patients
with non-alcoholic fatty liver disease (NAFLD). Subjects were randomized to either receive …